Publications by authors named "Celina Ang"

Claim this Profile
P
Perianal Fistulizing Crohn's Disease-Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus.
Serre-Yu Wong, Cathy Rowan, Elvira Diaz Brockmans, Cindy C Y Law, Elisabeth Giselbrecht, Celina Ang

Clin Gastroenterol Hepatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab.
Bernardo Stefanini, Claudia Angela Maria Fulgenzi, Bernhard Scheiner, James Korolewicz, Jaekyung Cheon, Celina Ang, Angelo Pirozzi, Yi-Hsiang Huang

J Hepatocell Carcinoma· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment.
Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, Salvatore Battaglia, Marco Enea, Angelo Pirozzi, Yi-Hsiang Huang, Pei-Chang Lee, Celina Ang

Hepatology· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab.
Meng Wu, Claudia A M Fulgenzi, Antonio D'Alessio, Alessio Cortellini, Ciro Celsa, Yi-Hsiang Huang, Angelo Pirozzi, Celina Ang

JHEP Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction.
Claudia Angela Maria Fulgenzi, Bernhard Scheiner, Antonio D'Alessio, Aman Mehan, Giulia F Manfredi, Celina Ang, Yi-Hsiang Huang, Pei-Chang Lee

JAMA Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplexed immunohistochemical analysis of the immune microenvironment of biliary tract cancers pre- & post-neoadjuvant chemotherapy: case series.
Sirish Dharmapuri, Rafael Cabal, Guray Akturk, Giorgio Ioannou, Sinem Ozbey, Celina Ang

Ann Transl Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
Ciro Celsa, Giuseppe Cabibbo, Claudia A M Fulgenzi, Bernhard Scheiner, Antonio D'Alessio, Celina Ang, Yi-Hsiang Huang, Pei-Chang Lee

J Hepatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma.
Lorenz Balcar, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Katharina Pomej, Pei-Chang Lee, Celina Ang, Yi-Hsiang Huang

JHEP Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.
Vincent Joerg, Bernhard Scheiner, Antonio D Alessio, Claudia A M Fulgenzi, Martin Schönlein, Yinghong Wang, Andrew Kuang, Pei-Chang Lee, Celina Ang, Yi-Hsiang Huang

Hepatol Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma.
Sirish Dharmapuri, Umut Özbek, Hiren Jethra, Tomi Jun, Thomas U Marron, Yi-Hsiang Huang, Ying-Hong Wang, Celina Ang

World J Gastrointest Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma.
Mathew Vithayathil, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Celina Ang, Pei-Chang Lee, Yi-Hsiang Huang

Hepatol Int· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal Adenocarcinoma.
Rebekah Macfie, Yael Berger, Hongdau Liu, Thomas Li, Sayed Imtiaz, Celina Ang

Ann Surg Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Thomas Talbot, Antonio D'Alessio, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Celina Ang, Yinghong Wang, Pei-Chang Lee, Yi-Hsiang Huang

Liver Int· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors.
Y Linda Wu, Grace van Hyfte, Umut Özbek, Marlene Reincke, Anuhya Gampa, Pei-Chang Lee, Yi-Hsiang Huang, Celina Ang

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma.
Mathew Vithayathil, Antonio D'Alessio, Claudia A M Fulgenzi, Naoshi Nishida, Martin Schönlein, Celina Ang, Pei-Chang Lee, Yi-Hsiang Huang

Liver Int· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study.
Claudia Angela Maria Fulgenzi, Jaekyung Cheon, Antonio D'Alessio, Naoshi Nishida, Celina Ang, Yi-Hsiang Huang

Eur J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Yi-Hsiang Huang, Celina Ang

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study.
Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden, Celina Ang, Pei-Chang Lee, Yi-Hsiang Huang

Hepatology· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.
Rohini Sharma, Anjana Pillai, Thomas Urban Marron, Petros Fessas, Anwaar Saeed, Yinghong Wang, Pei-Chang Lee, Yi-Hsiang Huang, Celina Ang

Hepatol Commun· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study.
Brett Marinelli, Edward Kim, Antonio D'Alessio, Mario Cedillo, Ishan Sinha, Yi-Hsiang Huang, Celina Ang

J Immunother Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pathological response after neoadjuvant chemotherapy on adjuvant therapy decisions and patient outcomes in gastrointestinal cancers.
Sheena Bhalla, Huili Zhu, Jung-Yi Lin, Umut Özbek, Eric J Wilck, Sanders Chang, Celina Ang

Cancer Rep (Hoboken)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma.
Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, Matthias Pinter, Lorenz Balcar, Yinghong Wang, Yi-Hsiang Huang, Celina Ang

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice.
David J Pinato, Thomas U Marron, Pallavi Shruti Mishra-Kalyani, Yutao Gong, Guo Wei, Yinghong Wang, Pei-Chang Lee, Yi-Hsiang Huang, Celina Ang

Eur J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma.
Petros Fessas, Muntaha Naeem, Matthias Pinter, Thomas U Marron, David Szafron, Yinghong Wang, Pei-Chang Lee, Yi-Hsiang Huang, Celina Ang

Liver Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-institutional analysis of racial disparities in clinicopathologic characteristics, treatment selections, and outcomes in advanced-stage pancreatic cancer patients.
Matthew Williams, Umut Özbek, Jung-Yi Lin, Celina Ang

Ann Pancreat Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis